Samsung Medical Center
| República da Coreia | Turquia | Áustria | |
| Fisioterapia | de $100 | de $50 | de $600 |
| Terapia com células estaminais para espondilite anquilosante | - | de $7,000 | de $20,000 |
| Terapia biológica | - | de $5,500 | de $20,000 |
O Hospital Severance — o maior hospital multidisciplinar da Coreia do Sul. Foi o primeiro no país a receber a prestigiosa acreditação americana pela qualidade do tratamento — JCI.
A especialização do Severance — oncologia, check-up (exame de saúde), cirurgia da coluna, cirurgia cardíaca e oftalmologia.
As conquistas do hospital incluem a primeira cirurgia cardíaca robótica na Coreia e a primeira implantação na Ásia de um disco espinhal artificial na região cervical.
Anualmente, o Hospital Severance recebe para tratamento mais de 1 000 000 de pacientes internados, dos quais 30 000 são estrangeiros.
O Dr. Ahn Tae Hoon formou-se no Montreal Heart Institute e lidera o Centro Cardiovascular do Hospital Naeun.
Diretor do Centro Ortopédico do Hospital Naeun – especialista em distúrbios articulares e cirurgia artroscópica.
Dr. Jang Hyo Kim is an orthopedic surgeon focused on joint preservation and complex reconstruction. He specializes in arthroscopy of the shoulder, knee, ankle, elbow, and wrist. He performs joint replacement of the shoulder, knee, ankle, elbow, and hip. His spine work includes cervical and lumbar instrumentation and fusion. He also performs discectomy, laminectomy, neuroplasty, and vertebroplasty. His practice includes fracture care and muscle and ligament repair.
He is an Adjunct Professor at Kyung Hee University. He serves as Director of the Joint Center at Very Good Hospital. He previously served as chief or director at Yeonggwang General, Songjeong Sarang, Sewoori–Daejeon, Seoul Welfare, and The Barun hospitals. He was an advisory member of the Gwangju–Jeonnam Workers’ Compensation Board. He is a full member of the Korean Orthopaedic Association (KOA) and the Korean Societies of Arthroscopy, Knee, Sports Medicine, Hip, Pain, and Obesity. He holds TPI therapy certification. He completed an Ilizarov fellowship in Kurgan, Russia. He also completed training in shoulder arthroscopy.
South Korea National Health Insurance covers biologics for ankylosing spondylitis under the Rare Intractable Disease program. Patients typically pay only 10% of treatment costs. Coverage requires specific clinical criteria like active sacroiliitis on imaging and failure of conventional therapies after 3 months.
Bookimed Expert Insight: Patients should prioritize university hospitals like Severance or Asan Medical Center for initial biologic approval. These academic centers manage high patient volumes and have streamlined systems for RID registration. Major facilities also utilize digital systems like BESTcare to track treatment history and prevent documentation errors during appeals.
Patient Consensus: Patients note that documenting every medication failure is vital for insurance approval. Many find that while initial drug costs seem high, the 10% co-pay cap makes long-term biologic therapy affordable.